postmenopausal osteoporosis การใช้

• "' Nilestriol "'( postmenopausal osteoporosis, but this formulation ultimately was not marketed.
• Inhibitors of IL-6 ( including estrogen ) are used to treat postmenopausal osteoporosis.
• Lindsay studied 217 postmenopausal osteoporosis patients who injected PTH or a placebo for a year.
• About 475, 000 patients use Fosamax to treat postmenopausal osteoporosis or Paget's disease of bone, Merck said.
• The drug combination "'bazedoxifene / conjugated estrogens "'( trade name "'Duavee "'in the menopause symptoms and postmenopausal osteoporosis.
• Reporting on the last five years, the researchers focused on 247 middle-aged and elderly women with postmenopausal osteoporosis.
• The Fosamax study followed 994 postmenopausal osteoporosis patients who had lost at least 25 percent of their spinal bone mass.
• Raloxifene is used for prevention and treatment of postmenopausal osteoporosis and breast cancer prevention in high-risk postmenopausal women with osteoporosis.
• Fosamax was approved by the Food and Drug Administration in 1995 for postmenopausal osteoporosis and is the top-selling osteoporosis drug.
• Osteoprotegerin has been used experimentally to decrease bone resorption in women with postmenopausal osteoporosis and in patients with lytic bone metastases.
• "Raloxifene will provide an important new choice for the prevention of postmenopausal osteoporosis, " said Willard Dere, medical director on Lilly's Evista development team.
• "Raloxifene will provide an important new choice for the prevention of postmenopausal osteoporosis, " said Willard Dere, medical director on Lilly's team developing Evista.
• Bethesda, Maryland : The Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee reviews Merck & Co .'s Fosamax for prevention of postmenopausal osteoporosis.
• Bethesda, Maryland : The Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee reviews Merck & AMP; Co .'s Fosamax for prevention of postmenopausal osteoporosis.
• Sterling submitted data to the FDA intended to support the effectiveness of Winstrol for postmenopausal osteoporosis and aplastic anemia in December, 1980 and August 1983 respectively.
• "Fosamax has met the preclinical and clinical criteria for its safe and effective use in prevention of postmenopausal osteoporosis, " said Dr . Samarendra Dutta, FDA medical officer.
• The reviews covered therapies for such ailments as hair loss, breast cancer, AIDS, diabetes, postmenopausal osteoporosis, alcoholism, asthma, glaucoma, multiple sclerosis, meningitis, attention-deficit-hyperactivity disorder, and sickle cell anemia.
• Including treatment of ovulatory dysfunction in the management of infertility, treatment and prevention of postmenopausal osteoporosis, treatment and reduction in risk of breast cancer and treatment of dyspareunia due to menopause.
• I think most physicians would agree with me that estrogen is generally the agent of choice for both prevention of accelerated bone loss and treatment of women who have postmenopausal osteoporosis,
• In April 1984, the FDA announced that the data was not sufficient, and withdrew the marketing authority for stanozolol for senile and postmenopausal osteoporosis and for raising hemoglobin levels in aplastic anemia.